Diagnostics and the neglected tropical diseases roadmap: setting the agenda for 2030.

WHO diagnostics neglected tropical diseases target product profiles

Journal

Transactions of the Royal Society of Tropical Medicine and Hygiene
ISSN: 1878-3503
Titre abrégé: Trans R Soc Trop Med Hyg
Pays: England
ID NLM: 7506129

Informations de publication

Date de publication:
28 01 2021
Historique:
received: 06 08 2020
revised: 07 10 2020
accepted: 16 10 2020
pubmed: 11 11 2020
medline: 25 6 2021
entrez: 10 11 2020
Statut: ppublish

Résumé

Accurate and reliable diagnostic tools are an essential requirement for neglected tropical diseases (NTDs) programmes. However, the NTD community has historically underinvested in the development and improvement of diagnostic tools, potentially undermining the successes achieved over the last 2 decades. Recognizing this, the WHO, in its newly released draft roadmap for NTD 2021-2030, has identified diagnostics as one of four priority areas requiring concerted action to reach the 2030 targets. As a result, WHO established a Diagnostics Technical Advisory Group (DTAG) to serve as the collaborative mechanism to drive progress in this area. Here, the purpose and role of the DTAG are described in the context of the challenges facing NTD programmes.

Identifiants

pubmed: 33169166
pii: 5965337
doi: 10.1093/trstmh/traa118
pmc: PMC7842105
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

129-135

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : NIAID NIH HHS
ID : R01 AI125160
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.

Auteurs

Ashley A Souza (AA)

Neglected Tropical Diseases Support Center, Task Force for Global Health, Atlanta, GA 30030, USA.

Camilla Ducker (C)

Consultant, World Health Organization, Geneva, Switzerland.

Daniel Argaw (D)

Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.

Jonathan D King (JD)

Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.

Anthony W Solomon (AW)

Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.

Marco A Biamonte (MA)

Drugs and Diagnostics for Tropical Diseases, San Diego, CA 92111, USA.

Rhea N Coler (RN)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.

Israel Cruz (I)

National School of Public Health, Instituto de Salud Carlos III, Madrid, Spain.

Veerle Lejon (V)

Institut de Recherche pour le Développement, University of Montpellier, Montpellier, France.

Bruno Levecke (B)

Department of Virology, Parasitology and Immunology, Ghent University, Faculty of Veterinary Medicine, Salisburylaan 133, B-9820 Merelbeke, Belgium.

Fabricio K Marchini (FK)

Carlos Chagas Institute, Fiocruz Parana, Curitiba, Parana, Brazil.

Michael Marks (M)

Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK.

Pascal Millet (P)

Laboratoire de Parasitologie, Université de Bordeaux, Bordeaux, France.

Sammy M Njenga (SM)

Kenya Medical Research Institute, Nairobi, Kenya.

Rahmah Noordin (R)

Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Pengang, Malaysia.

René Paulussen (R)

Mondial Diagnostics, Amsterdam, the Netherlands.

Esvawaran Sreekumar (E)

Molecular Virology Laboratory, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, India.

Patrick J Lammie (PJ)

Neglected Tropical Diseases Support Center, Task Force for Global Health, Atlanta, GA 30030, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH